INTERIM RESULTS FROM THE OCRIPLASMIN FOR VITREOMACULAR TRACTION INTRAVITREAL INJECTION DECISIONS (OVIID-I) TRIAL

被引:0
|
作者
Chang, Andrew [1 ,2 ]
机构
[1] Sydney Eye Hosp, Sydney, NSW, Australia
[2] Sydney Retina Clin & Day Surg, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2
引用
收藏
页码:61 / 61
页数:1
相关论文
共 50 条
  • [41] Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis
    Chu, Michael P.
    Brody, Joshua
    Kohrt, Holbrook E.
    Frank, Matthew J.
    Khodadoust, Michael
    Reddy, Sunil
    Advani, Ranjana H.
    Gupta, Neel K.
    Laport, Ginna
    Maeda, Lauren S.
    Meyer, Everett
    Miklos, David B.
    Negrin, Robert
    Rezvani, Andrew R.
    Weng, Wen-Kai
    Sheehan, Kevin
    Faham, Malek
    Czerwinski, Debra K.
    Okada, Ami
    Levy, Ronald
    BLOOD, 2015, 126 (23)
  • [42] Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
    Lin, Pingping
    Li, Chengqian
    Liu, Yanping
    Sun, Feifei
    Hsieh, Tsung-Han
    Ma, Yaping
    Gao, Xiaomeng
    Yu, Qing
    Cao, Yu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] RETREATMENT WITH TELAPREVIR/PEG-IFN/RBV AFTER A SHORT EXPOSURE TO TELAPREVIR IN PHASE I STUDIES: INTERIM RESULTS FROM A PHASE IIIB ROLLOVER TRIAL (C219)
    Sarrazin, Christoph
    Reesink, Hendrik W.
    Zeuzem, Stefan
    Weegink, Christine J.
    Luo, Donghan
    Witek, James
    Kieffer, Tara L.
    Bartels, Doug J.
    Dierynck, Inge
    De Meyer, Sandra
    Picchio, Gaston
    HEPATOLOGY, 2011, 54 : 377A - 378A
  • [44] Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
    Aggarwal, Charu
    Prawira, Amy
    Antonia, Scott
    Rahma, Osama
    Tolcher, Anthony
    Cohen, Roger B.
    Lou, Yanyan
    Hauke, Ralph
    Vogelzang, Nicholas
    Zandberg, Dan P.
    Kalebasty, Arash Rezazadeh
    Atkinson, Victoria
    Adjei, Alex A.
    Seetharam, Mahesh
    Birnbaum, Ariel
    Weickhardt, Andrew
    Ganju, Vinod
    Joshua, Anthony M.
    Cavallo, Rosetta
    Peng, Linda
    Zhang, Xiaoyu
    Kaul, Sanjeev
    Baughman, Jan
    Bonvini, Ezio
    Moore, Paul A.
    Goldberg, Stacie M.
    Arnaldez, Fernanda, I
    Ferris, Robert L.
    Lakhani, Nehal J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [45] Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
    Carmela Rozera
    Giancarlo Antonini Cappellini
    Giuseppina D’Agostino
    Laura Santodonato
    Luciano Castiello
    Francesca Urbani
    Iole Macchia
    Eleonora Aricò
    Ida Casorelli
    Paola Sestili
    Enrica Montefiore
    Domenica Monque
    Davide Carlei
    Mariarosaria Napolitano
    Paola Rizza
    Federica Moschella
    Carla Buccione
    Roberto Belli
    Enrico Proietti
    Antonio Pavan
    Paolo Marchetti
    Filippo Belardelli
    Imerio Capone
    Journal of Translational Medicine, 13
  • [46] Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
    Rozera, Carmela
    Cappellini, Giancarlo Antonini
    D'Agostino, Giuseppina
    Santodonato, Laura
    Castiello, Luciano
    Urbani, Francesca
    Macchia, Iole
    Arico, Eleonora
    Casorelli, Ida
    Sestili, Paola
    Montefiore, Enrica
    Monque, Domenica
    Carlei, Davide
    Napolitano, Mariarosaria
    Rizza, Paola
    Moschella, Federica
    Buccione, Carla
    Belli, Roberto
    Proietti, Enrico
    Pavan, Antonio
    Marchetti, Paolo
    Belardelli, Filippo
    Capone, Imerio
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [47] Intratumoral injection of LTX-315 in combination with pembrolizumab in patients with advanced melanoma refractory to prior PD-1/PD-L1 therapy: Interim results from the ATLAS-IT-05 trial
    Dalle, S.
    Marron, T. U.
    Robert, C.
    Aljabri, B.
    Nyakas, M. S.
    Slot, K. Bruins
    Sundvold, V.
    Rekdal, O.
    Sveinbjornsson, B.
    Currie, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S636 - S636
  • [48] The UNVEIL (Utilizing raNibizumab intraVitrEal Injection in reaL-world setting) study interim results: Effectiveness and safety of ranibizumab in the treatment of neovascular age-related macular degeneration under real-life conditions in patients from Africa, Asia and the Middle East
    Mahgoub, Mohamed
    Yadav, Naresh
    Mester, Viktoria
    Legodi, Kgaogelo
    Kim, Hakyoung
    Wu, Eddy
    Hristoskova, Sashka
    DiTommaso, Shelley
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [49] Sequential 90Y selective internal radiation therapy (SIRT) and stereotactic body radiation therapy (SBRT) using 90Y PETbased absorbed dose maps: Interim results from a Phase I clinical trial
    Polan, Daniel
    Mikell, Justin
    Fitzpatrick, Kellen
    Gemmete, Joseph
    Christensen, Jared
    Anbari, Hassan
    Kapoor, Baljendra
    Roseland, Molly
    Millet, John
    Evans, Joseph
    Schipper, Matthew
    Lawrence, Theodore
    Cuneo, Kyle
    Dewaraja, Yuni
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [50] Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
    Nolan, Terry M.
    Deliyannis, Georgia
    Griffith, Maryanne
    Braat, Sabine
    Allen, Lilith F.
    Audsley, Jennifer
    Chung, Amy W.
    Ciula, Marcin
    Gherardin, Nicholas A.
    Giles, Michelle L.
    Gordon, Tom P.
    Grimley, Samantha L.
    Horng, Lana
    Jackson, David C.
    Juno, Jennifer A.
    Kedzierska, Katherine
    Kent, Stephen J.
    Lewin, Sharon R.
    Littlejohn, Mason
    McQuilten, Hayley A.
    Mordant, Francesca L.
    Nguyen, Thi H. O.
    Soo, Vanessa Pac
    Price, Briony
    Purcell, Damian F. J.
    Ramanathan, Pradhipa
    Redmond, Samuel J.
    Rockman, Steven
    Ruan, Zheng
    Sasadeusz, Joseph
    Simpson, Julie A.
    Subbarao, Kanta
    Fabb, Stewart A.
    Payne, Thomas J.
    Takanashi, Asuka
    Tan, Chee Wah
    Torresi, Joseph
    Wang, Jing Jing
    Wang, Lin-Fa
    Al-Wassiti, Hareth
    Wong, Chinn Yi
    Zaloumis, Sophie
    Pouton, Colin W.
    Godfrey, Dale I.
    EBIOMEDICINE, 2023, 98